Gueta Keren, Molotski Natali, Gerchikov Natalie, Mor Eyal, Savion Shoshana, Fein Amos, Toder Vladimir, Shomron Noam, Torchinsky Arkady
Department of Cell and Developmental Biology, Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv, 69978, Israel.
BMC Dev Biol. 2010 Feb 21;10:20. doi: 10.1186/1471-213X-10-20.
In a large number of studies, members of the microRNA (miRNA)-34 family such as miRNA-34a, miRNA-34b, miRNA-34c, as well as miRNA-125b and miRNA-155, have been shown to be regulators of apoptosis. The ability of these miRNAs to perform this function is mainly attributed to their ability to interact with the p53 tumor suppressor, which is a powerful regulator of the teratologic susceptibility of embryos. We chose to explore whether miRNA-34a/b/c, miRNA-125b and miRNA-155 may play a role in teratogenesis by using p53+/- pregnant mice treated with cyclophosphamide (CP) as a model. We evaluated how CP-induced alterations in the expression of these miRNAs in the embryonic limbs correlate with embryonic p53 genotype and CP-induced limb phenotypes.
The limbs of p53 positive embryos were more sensitive to CP-induced teratogenic insult than the limbs of p53 negative embryos. The hindlimbs were more severely affected than the forelimbs. Robust miRNA-34a expression was observed in the fore- and hindlimbs of p53+/+ embryos exposed to 12.5 mg/kg CP. The dose of 20 mg/kg CP induced almost a two-fold increase in the level of miRNA-34a expression as compared to that exhibited by p53+/+ embryos exposed to a lower dose. Increased miRNA-34b and miRNA-34c expression was also observed. Of note, this dose activated miRNA-34a and miRNA-34c in the forelimbs of p53-/- embryos. When embryos were exposed to 40 mg/kg CP, the expression pattern of the miRNA-34a/b/c was identical to that registered in the limbs of embryos exposed to 20 mg/kg CP. However, this dose suppressed miRNA-125b and miRNA-155 expression in the fore- and hindlimbs of p53+/+ embryos.
This study demonstrates that teratogen-induced limb dysmorphogenesis may be associated with alterations in miRNA-34, miRNA-125b and miRNA-155 expression. It also suggests for the first time that p53-independent mechanisms exist contributing to teratogen-induced activation of miRNA-34a and miRNA-34c. At the same time, teratogen-induced suppression of miRNA-125b and miRNA-155 expression may be p53 dependent. The analysis of correlations between the expression pattern of the tested miRNAs and CP induced limb phenotypes implies that miRNAs regulating apoptosis may differ from each other with respect to their functional role in teratogenesis: some miRNAs act to protect embryos, whereas other miRNAs boost a teratogen-induced process of maldevelopment to induce embryonic death.
在大量研究中,微小RNA(miRNA)-34家族成员,如miRNA-34a、miRNA-34b、miRNA-34c,以及miRNA-125b和miRNA-155,已被证明是细胞凋亡的调节因子。这些miRNA执行此功能的能力主要归因于它们与p53肿瘤抑制因子相互作用的能力,p53是胚胎致畸易感性的强大调节因子。我们选择以环磷酰胺(CP)处理的p53+/-怀孕小鼠为模型,探讨miRNA-34a/b/c、miRNA-125b和miRNA-155是否可能在致畸过程中发挥作用。我们评估了CP诱导的这些miRNA在胚胎肢体中的表达变化与胚胎p53基因型和CP诱导的肢体表型之间的相关性。
p53阳性胚胎的肢体比p53阴性胚胎的肢体对CP诱导的致畸损伤更敏感。后肢比前肢受影响更严重。在暴露于12.5mg/kg CP的p53+/+胚胎的前肢和后肢中观察到miRNA-34a的强烈表达。与暴露于较低剂量的p53+/+胚胎相比,20mg/kg CP的剂量使miRNA-34a的表达水平几乎增加了两倍。还观察到miRNA-34b和miRNA-34c的表达增加。值得注意的是,该剂量激活了p53-/-胚胎前肢中的miRNA-34a和miRNA-34c。当胚胎暴露于40mg/kg CP时,miRNA-34a/b/c的表达模式与暴露于20mg/kg CP的胚胎肢体中记录的模式相同。然而,该剂量抑制了p53+/+胚胎前肢和后肢中miRNA-125b和miRNA-155的表达。
本研究表明,致畸剂诱导的肢体畸形可能与miRNA-34、miRNA-125b和miRNA-155表达的改变有关。它还首次表明存在不依赖p53的机制导致致畸剂诱导的miRNA-34a和miRNA-34c的激活。同时,致畸剂诱导的miRNA-125b和miRNA-155表达的抑制可能依赖于p53。对所测试的miRNA表达模式与CP诱导的肢体表型之间相关性的分析表明,调节细胞凋亡的miRNA在致畸过程中的功能作用可能彼此不同:一些miRNA起到保护胚胎的作用,而其他miRNA则促进致畸剂诱导的发育异常过程以诱导胚胎死亡。